FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagede.medizininformatikinitiative.kerndatensatz.onkologie
Resource TypeCarePlan
IdCarePlan-mii-exa-onko-tumorkonferenz-molekular.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

No narrative content found in resource


Source1

{
  "resourceType": "CarePlan",
  "id": "mii-exa-onko-tumorkonferenz-molekular",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-tumorkonferenz|2026.0.1"
    ]
  },
  "status": "active",
  "intent": "plan",
  "category": [
    {
      "coding": [
        {
          "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapieplanung-typ",
          "code": "praeth"
        }
      ],
      "text": "Molekulares Tumorboard"
    }
  ],
  "subject": {
    "reference": "Patient/example"
  },
  "created": "2024-01-15",
  "addresses": [
    {
      "reference": "Condition/primaertumor-example"
    }
  ],
  "activity": [
    {
      "detail": {
        "code": {
          "coding": [
            {
              "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ",
              "code": "ZS"
            }
          ],
          "text": "Zielgerichtete Anti-HER2 Therapie"
        },
        "status": "not-started",
        "description": "Basierend auf HER2-Amplifikation: Trastuzumab + Pertuzumab Kombination empfohlen"
      }
    },
    {
      "detail": {
        "code": {
          "coding": [
            {
              "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ",
              "code": "CZ"
            }
          ],
          "text": "Chemotherapie + CDK4/6 Inhibitor"
        },
        "status": "not-started",
        "description": "Alternative basierend auf HR+/HER2- Status: Palbociclib + Letrozol"
      }
    },
    {
      "detail": {
        "code": {
          "coding": [
            {
              "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ",
              "code": "ST"
            }
          ],
          "text": "Strahlentherapie"
        },
        "status": "not-started",
        "description": "Adjuvante Bestrahlung nach Operation"
      }
    }
  ]
}